Blog
RSS FeedPosted by Michael Wonder on 21 Jun 2022
Medicare could’ve saved $3.6 billion by buying drugs at same prices as Mark Cuban’s online pharmacy, according to a new study
22 June 2022 - Medicare’s drug program could have saved up to $3.6 billion in 2020 by mirroring the pricing ...
Posted by Michael Wonder on 17 Jun 2022
NICE recommends new targeted treatment for early breast cancer
16 June 2022 - NICE has provisionally approved a new treatment for early breast cancer that it says will benefit ...
Posted by Michael Wonder on 30 May 2022
Why won’t the FDA let doctors prescribe fluvoxamine for COVID?
30 May 2022 - Trials show it keeps patients from getting sicker, but the agency won’t approve its emergency use. ...
Posted by Michael Wonder on 27 May 2022
Medicare premium increase from Alzheimer’s drug to be lowered next year
27 May 2022 - Health and Human Services Secretary Xavier Becerra announced on Friday that Medicare premiums would be adjusted ...
Posted by Michael Wonder on 25 May 2022
Medicare spending on drugs with accelerated approval
24 May 2022 - The U.S. FDA provides accelerated approval to drugs on the basis of surrogate end points deemed to ...
Posted by Michael Wonder on 18 May 2022
CMS unveils more user friendly Medicare website
18 May 2022 - New Medicare.gov will incorporate public feedback and make it easier to compare, choose, and understand Medicare ...
Posted by Michael Wonder on 12 May 2022
Federal investigators find Medicare Advantage plans too often deny, delay needed care
10 May 2022 - Medicare Advantage plans that provide health insurance coverage to millions of US seniors deny some medically ...
Posted by Michael Wonder on 09 May 2022
The Center for Medicare and Medicaid Innovation - toward value based care
9 May 2022 - Before the enactment of the Patient Protection and Affordable Care Act in 2010, experimentation with Medicare or ...
Posted by Michael Wonder on 05 May 2022
Aadi Bioscience announces unique permanent J code issued for Fyarro from Centers for Medicare and Medicaid Services
4 May 2022 - Effective 1 July J code will enable a streamlined reimbursement process for Fyarro. ...
Posted by Michael Wonder on 05 May 2022
Your money or your life - the high cost of cancer drugs under Medicare Part D
4 May 2022 - The financial burden associated with orally administered anti-cancer drugs can be overwhelming for Medicare beneficiaries. ...
Posted by Michael Wonder on 19 Apr 2022
Medicare’s decision not to fund Aduhelm changes landscape for US pharma industry
19 April 2022 - The decision by the agency responsible for Medicare to restrict coverage of Biogen’s Alzheimer’s drug aducanumab ...
Posted by Michael Wonder on 19 Apr 2022
Prioritising reference products over biosimilars led to millions of missed savings for Part D
20 April 2022 - Medicare Part D plans missed out on between $84 million and $143 million in savings by ...
Posted by Michael Wonder on 07 Apr 2022
CMS finalises Medicare coverage policy for monoclonal antibodies directed against amyloid for the treatment of Alzheimer’s disease
7 April 2022 - Today, the CMS released a national policy for coverage of aducanumab (Aduhelm) and any future monoclonal antibodies ...
Posted by Michael Wonder on 06 Apr 2022
Inside a campaign to get Medicare coverage for a new Alzheimer’s drug
6 April 2022 - The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and ...
Posted by Michael Wonder on 07 Mar 2022
Medicare bulk billing rates surge across our health system
6 March 2022 - Essential medical care is more affordable than ever before with the number of Australians receiving essential medical ...